Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD

American Journal of Kidney Diseases

Volumn 58, Issue 6, 2011, Pages 886-893

  Bhavsar, Nrupen A ^a,b   Appel, Lawrence J ^a,b,c   Kusek, John W ^d   Contreras, Gabriel ^e   Bakris, George ^f   Coresh, Josef ^a,b,c   Astor, Brad C ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

beta trace protein; cystatin C; End stage renal disease; iothalamate glomerular filtration rate; serum creatinine

Indexed keywords

AMLODIPINE; BETA TRACE PROTEIN; CREATININE; CYSTATIN C; METOPROLOL; PROTEIN; RAMIPRIL; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; HYPERTENSIVE CHRONIC KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL;

AFRICAN AMERICANS; AGED; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; INTRAMOLECULAR OXIDOREDUCTASES; KIDNEY FAILURE, CHRONIC; LIPOCALINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL INSUFFICIENCY, CHRONIC;

EID: 81755174330     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.07.018     Document Type: Article

References (35)

1. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
2. M.J. Klag, P.K. Whelton, B.L. Randall, J.D. Neaton, F.L. Brancati, and J. Stamler End-stage renal disease in African-American and white men 16-Year MRFIT findings JAMA 277 16 1997 1293 1298 (Pubitemid 27194353)
3. M.G. Shlipak, M.J. Sarnak, and R. Katz Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 20 2005 2049 2060 (Pubitemid 40664306)
4. US Renal Data System USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2009 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
5. L.A. Stevens, C.H. Schmid, and T. Greene Factors other than glomerular filtration rate affect serum cystatin C levels Kidney Int 75 6 2009 652 660
6. F. Priem, H. Althaus, M. Birnbaum, P. Sinha, H.S. Conradt, and K. Jung Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range Clin Chem 45 4 1999 567 568 (Pubitemid 29165968)
7. M. Kobata, A. Shimizu, and H. Rinno Beta-trace protein, a new marker of GFR, may predict the early prognostic stages of patients with type 2 diabetic nephropathy J Clin Lab Anal 18 4 2004 237 239 (Pubitemid 38902625)
8. D.N. Melegos, L. Grass, A. Pierratos, and E.P. Diamandis Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure Urology 53 1 1999 32 37 (Pubitemid 29016610)
9. U. Poge, T.M. Gerhardt, and B. Stoffel-Wagner Beta-trace protein is an alternative marker for glomerular filtration rate in renal transplantation patients Clin Chem 51 8 2005 1531 1533 (Pubitemid 41060895)
10. C. Donadio, A. Lucchesi, M. Ardini, E. Donadio, and R. Giordani Serum levels of beta-trace protein and glomerular filtration ratepreliminary results J Pharm Biomed Anal 32 4-5 2003 1099 1104 (Pubitemid 36951987)
11. L.Y. Agodoa, L. Appel, and G.L. Bakris Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial JAMA 285 21 2001 2719 2728 (Pubitemid 32525368)
12. J. Lewis, T. Greene, and L. Appel A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension J Am Soc Nephrol 15 12 2004 3175 3183 (Pubitemid 39578850)
13. L.J. Appel, J. Middleton, and E.R. Miller III The rationale and design of the AASK cohort study J Am Soc Nephrol 14(7) suppl 2 2003 S166 S172
14. J.J. Gassman, T. Greene, and J.T. Wright Jr Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK) J Am Soc Nephrol 14(7) suppl 2 2003 S154 S165
15. M. Sika, J. Lewis, and J. Douglas Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) clinical trial and cohort study Am J Kidney Dis 50 1 2007 78 89 89 e71
16. R.D. Toto, K.A. Kirk, and J. Coresh Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study J Am Soc Nephrol 8 2 1997 279 287 (Pubitemid 127455883)
17. J.P. Fine A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 446 1999 496 509
18. C.C. Stucky, R.J. Gray, N. Wasif, A.C. Dueck, and B.A. Pockaj Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer Ann Surg Oncol 17 suppl 3 2010 330 337
19. F.E. Harrell Jr, K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 4 1996 361 387 (Pubitemid 26072233)
20. M.J. Pencina, R.B. D'Agostino Sr, and E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 1 2011 11 21
21. C.Y. Hsu, G.M. Chertow, and G.C. Curhan Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency Kidney Int 61 5 2002 1567 1576 (Pubitemid 34437910)
22. O. Shemesh, H. Golbetz, J.P. Kriss, and B.D. Myers Limitations of creatinine as a filtration marker in glomerulopathic patients Kidney Int 28 5 1985 830 838 (Pubitemid 16156326)
23. A. Bokenkamp, I. Franke, and M. Schlieber Beta-trace proteina marker of kidney function in children: "Original research communication-clinical investigation." Clin Biochem 40 13-14 2007 969 975 (Pubitemid 47301796)
24. A. Hoffmann, M. Nimtz, and H.S. Conradt Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases Glycobiology 7 4 1997 499 506 (Pubitemid 27246723)
25. C.A. White, A. Akbari, and S. Doucette A novel equation to estimate glomerular filtration rate using beta-trace protein Clin Chem 53 11 2007 1965 1968 (Pubitemid 350036043)
26. K.S. Spanaus, B. Kollerits, E. Ritz, M. Hersberger, F. Kronenberg, and A. von Eckardstein Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease Clin Chem 56 5 2010 740 749
27. M. Mussap, M. Dalla Vestra, and P. Fioretto Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients Kidney Int 61 4 2002 1453 1461 (Pubitemid 34304506)
28. O.F. Laterza, C.P. Price, and M.G. Scott Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 48 5 2002 699 707 (Pubitemid 34439101)
29. V. Menon, M.G. Shlipak, and X. Wang Cystatin C as a risk factor for outcomes in chronic kidney disease Ann Intern Med 147 1 2007 19 27 (Pubitemid 351664630)
30. L.A. Stevens, J. Coresh, and C.H. Schmid Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD Am J Kidney Dis 51 3 2008 395 406 (Pubitemid 351273480)
31. M. Madero, and M.J. Sarnak Association of cystatin C with adverse outcomes Curr Opin Nephrol Hypertens 18 3 2009 258 263
32. B.C. Astor, A.S. Levey, L.A. Stevens, F. Van Lente, E. Selvin, and J. Coresh Method of glomerular filtration rate estimation affects prediction of mortality risk J Am Soc Nephrol 20 10 2009 2214 2222
33. Y.T. Kwong, L.A. Stevens, and E. Selvin Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations Am J Kidney Dis 56 1 2010 39 49
34. A.S. Levey, T. Greene, and M.D. Schluchter Glomerular filtration rate measurements in clinical trials Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group J Am Soc Nephrol 4 5 1993 1159 1171
35. 99mTc-DTPA, and inulin The Modification of Diet in Renal Disease Study Am J Kidney Dis 16 3 1990 224 235 (Pubitemid 20342441)